Equities analysts expect that Sharps Compliance Corp. (NASDAQ:SMED) will announce $11.24 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Sharps Compliance’s earnings, with the highest sales estimate coming in at $11.70 million and the lowest estimate coming in at $11.00 million. Sharps Compliance reported sales of $10.36 million during the same quarter last year, which indicates a positive year over year growth rate of 8.5%. The firm is expected to report its next quarterly earnings report before the market opens on Tuesday, August 14th.
According to Zacks, analysts expect that Sharps Compliance will report full-year sales of $41.51 million for the current fiscal year, with estimates ranging from $41.20 million to $42.10 million. For the next fiscal year, analysts expect that the firm will report sales of $43.53 million per share, with estimates ranging from $42.10 million to $44.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Sharps Compliance.
Several equities analysts have weighed in on the company. TheStreet downgraded Sharps Compliance from a “c-” rating to a “d+” rating in a research report on Wednesday, June 27th. Zacks Investment Research upgraded shares of Sharps Compliance from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 3rd. Stifel Nicolaus cut shares of Sharps Compliance from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $6.00 to $4.00 in a report on Monday, April 30th. Finally, ValuEngine upgraded shares of Sharps Compliance from a “sell” rating to a “hold” rating in a report on Saturday, June 2nd. Three research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Sharps Compliance currently has a consensus rating of “Hold” and a consensus price target of $5.50.
Sharps Compliance stock traded down $0.04 during mid-day trading on Tuesday, hitting $3.40. 5,526 shares of the company were exchanged, compared to its average volume of 83,878. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.02 and a current ratio of 2.70. The company has a market capitalization of $55.32 million, a price-to-earnings ratio of -85.00, a PEG ratio of 1.62 and a beta of 0.53. Sharps Compliance has a 12-month low of $3.40 and a 12-month high of $5.73.
A number of hedge funds have recently added to or reduced their stakes in SMED. Wells Fargo & Company MN bought a new stake in Sharps Compliance during the fourth quarter valued at about $583,000. Renaissance Technologies LLC grew its position in shares of Sharps Compliance by 8.3% in the 4th quarter. Renaissance Technologies LLC now owns 432,300 shares of the industrial products company’s stock valued at $1,768,000 after acquiring an additional 33,300 shares during the period. Deutsche Bank AG boosted its holdings in shares of Sharps Compliance by 1,194.7% during the 4th quarter. Deutsche Bank AG now owns 28,484 shares of the industrial products company’s stock worth $116,000 after buying an additional 26,284 shares during the period. Thompson Davis & CO. Inc. boosted its holdings in shares of Sharps Compliance by 557.2% during the 1st quarter. Thompson Davis & CO. Inc. now owns 48,894 shares of the industrial products company’s stock worth $222,000 after buying an additional 41,454 shares during the period. Finally, Marathon Capital Management bought a new stake in shares of Sharps Compliance during the 1st quarter worth about $249,000. Institutional investors own 23.27% of the company’s stock.
About Sharps Compliance
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Featured Article: How Short Selling Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.